NewsBenzingaCodexis firma un acuerdo con un innovador de medicamentos siARN no revelado para explorar la síntesis de fragmentos con definición estereoespecífica utilizando su plataforma de fabricación ECO Synthesis Codexis firma un acuerdo con un innovador de medicamentos siARN no revelado para explorar la síntesis de fragmentos con definición estereoespecífica utilizando su plataforma de fabricación ECO Synthesis Benzinga 2026.09.28 10:03 (GMT+0) Open on Benzinga Other news Why Is IREN Stock Surging Monday? Cleveland-Cliffs Q3 2026 Earnings Call Transcript On Sunday October 18, 2026 TeraWulf CEO Paul Prager Posted On X "$WULF is NOT a neocloud. $WULF IS an energy infrastructure company. We match long term investment grade energy supply with long term HPC/AI off-take. We finance our projects competitively... Cosmos Health Expects Q4 Sales Of ~$15M, Gross Profit Of ~$10.5M With Gross Margin Of ~70% Jefferies Maintains Hold on Kinetik Holdings, Lowers Price Target to $54 Stephens & Co. Maintains Equal-Weight on Regions Financial, Lowers Price Target to $30
On Sunday October 18, 2026 TeraWulf CEO Paul Prager Posted On X "$WULF is NOT a neocloud. $WULF IS an energy infrastructure company. We match long term investment grade energy supply with long term HPC/AI off-take. We finance our projects competitively...
